IP
IndiaPulse

STARHEALTH

Small Cap

Star Health and Allied Insurance Company Limited

Financial Services

Star Health and Allied Insurance Company Limited operates in Health Insurance, within the Financial Services sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹523.8
+5.05 · +0.97%
Quote09 Jun, 10:02 am
Fundamentals07 Jun 2026 · screener
Score08 Jun, 11:00 pm · v4.2-nightly
Tags02 May 2026
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Weak fundamentals, management trust is acceptable, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
OVERVALUED
30

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Mixed Trust
64

low confidence · 0/0 claims checked

Technical
Bullish
60

Timing lens: price trend and sector relative strength.

Result consistency
weak
39

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 31 Mar 2026

Excellent · 80/100

Rev +14% YoY · PAT +11000% YoY · margin expansion · operating leverage

Filed 28 Apr 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹4,648 Cr+13.9%+1.8%
EBITDA₹148 Cr+2214.3%-14.0%
Operating margin3.0%+300 bps-100 bps
PAT₹111 Cr+11000.0%-13.3%
PAT margin2.4%+237 bps-41 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business and thesis

Issuer presentation review pending

Star Health and Allied Insurance Company Limited operates in Health Insurance, within the Financial Services sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 31 Mar 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Technical timing lens

Trend score and candlestick chart

60Bullish

SMA20 +12.6% / mo · near 52W high

Stock trend: 60
Sector RS:

Technical chart

STARHEALTHdaily · 6M+11.2%
Latest close ₹521.40 on 2026-06-09
Bar
+1.0%
RSI
53
MACD hist
-1.55
52W pos
62%
Hover for OHLC, volume, and indicators. Use range buttons above the chart to zoom.
₹408₹455₹501₹548₹59552H52L2025-122026-03Vol2025-122026-012026-032026-042026-06
Up bar
Down bar
Volume
Result date
SMA 50
RSI(14)

Technical trend read

Mixed signals

Signals are conflicting — long-term trend unclear. RSI 53. Wait for confirmation.

  • SMA20 rising (~1.3% over last month) — short-term momentum positive.
  • RSI(14) at 53 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 11% off 52W high · 25% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Deep research

Valuation, score drivers, trust methodology, financials, and peers

Use these sections after reviewing the decision summary, latest result, thesis, management accountability, and technical timing above.

30U-SCORE
OVERVALUED

Fundamental score breakdown

OVERVALUED
Valuation1/30
Growth12/25
Quality0/20
Balance Sheet8/15
Cash Flow6/10
Piotroski
6/9 (+3)
Penalties
0
Raw sum
30

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

30/100 · OVERVALUED

Positive drivers

  • Cash flow contributes 6/10 to the score.
  • Balance sheet contributes 8/15 to the score.
  • Growth contributes 12/25 to the score.

Main drags

  • Fair-value margin of safety is negative at -67.6%.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
  • Valuation is weaker at 1/30; verify the latest quarterly trend.
Sector valuation model

Insurance valuation: embedded value and VNB quality

Insurance economics depend on long-duration book value and new-business profitability.

Insurance P/EV
Primary lens
P/embedded value where available, plus VNB growth and margin.
Secondary checks
Persistency, product mix, solvency, distribution strength.
Main risk check
Accounting profit is less useful than embedded value quality.
PE
55.6
PB
3.2
EV/EBITDA
42.2
ROE
6.7%
ROCE
8.6%
FCF Yield
0.7%
Debt/Equity
0.1
MoS
-67.6%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 08 Jun 2026
v4.2-nightly
Final score
30
Previous: 30
Verdict
OVERVALUED
Previous: OVERVALUED
Margin of safety
-67.6%
Previous: -64.8%

Score history

12 stored score snapshots. Latest stored move: +0 points.

08 Jun 2026
v4.2-nightly
30
30
30
30
30
30
30
30
30
30
30
30

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Trust Score
64Mixed Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Mixed Trust: Claim history is still being built. It ranks around the 42nd percentile of the scored universe and 59th percentile within Financial Services. Main check: financial discipline is weak at 30/100.

Healthy Trust Lite: Promoter holding is 58%. Key concern: 2 latest quarters had PAT decline worse than 25% YoY.

Computed 08 Jun 2026
management-trust-v1
104 docs indexed · 42 concall links
Score band
Mixed Trust

Usable, but needs evidence. Treat guidance with a margin of safety.

Relative rank
42nd percentile

overall median 67 · Financial Services: 59th pctile, median 62 · Small: 47th pctile, median 65

Evidence depth
Financial-only

104 documents indexed, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Mixed Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
86
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
80
strong · leverage and solvency
Discipline
30
weak · capital discipline
Results
39
weak · quarterly consistency

Trust positives

  • Promoter holding is 58%.
  • Promoter pledge is zero.
  • FCF yield is positive at 0.7%.
  • 4 years of positive FCF.

Trust risks

  • 2 latest quarters had PAT decline worse than 25% YoY.
  • ROE is low at 6.7%.
  • ROCE trend is -4.4%.
  • Revenue CAGR is 14% but EPS CAGR is -3%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Intrinsic value

Graham Number
₹186.36
-181.1% MoS
DCF Fair PE
33.0
DCF Fair Value
₹312.51
-67.6% MoS
PEG
2.78

Fundamentals

Valuation

P/E
55.60
P/B
3.23
EV/EBITDA
42.20
Market Cap
30950.00Cr

Profitability

ROE
6.70%
ROCE
8.57%
ROA
2.36%
Dividend Y

Growth (CAGR)

Revenue 5Y
29.00%
EPS 5Y
20.00%
Revenue 3Y
14.00%
EPS 3Y
-3.00%

Balance Sheet

Debt/Equity
0.05
Interest Coverage
Altman Z
2.86
Book Value
163.00

Cash Flow

FCF Yield
0.74%
FCF Positive Y
4/5
OCF
1379.00 Cr
EPS TTM
9.47

Shareholding

Promoter Hold
57.98%
Promoter Pledge
0.00%
Momentum 52W
65%

Financial History

Updated 9/6/2026

Revenue

₹ Cr
Latest: 10.6k-12.3% vs prev
018kMar 2026: 17.8kMar 2025: 16.1kMar 2024: 14.0kMar 2023: 12.1kMar 2022: 10.6kFY26FY25FY24FY23FY22

Net Profit

₹ Cr
No data

Return on Equity

%
No data
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.